Advyzon Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.4M Sell
3,699
-290
-7% -$294K 0.3% 78
2025
Q4
$4.29M Buy
3,989
+2,427
+155% +$2.32M 0.5% 43
2025
Q3
$1.19M Sell
1,562
-488
-24% -$363K 0.2% 115
2025
Q2
$1.6M Buy
2,050
+835
+69% +$649K 0.35% 62
2025
Q1
$1M Buy
1,215
+337
+38% +$280K 0.35% 57
2024
Q4
$678K Buy
+878
New +$727K 0.26% 79

Other funds holding LLY

Advyzon Investment Management's LLY Position: Q1 2026 in Review

Advyzon Investment Management reduced its Eli Lilly (LLY) stake by 7.3% in Q1 2026, selling an estimated $294K and leaving 3,699 shares worth $3.4M. The position accounts for 0.3% of the portfolio, ranked #78.

Advyzon Investment Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.29M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Advyzon Investment Management held 3,699 shares of Eli Lilly worth $3.4M as of Q1 2026.
  • Advyzon Investment Management sold 290 Eli Lilly shares in Q1 2026, an estimated $294K.
  • Eli Lilly made up 0.3% of Advyzon Investment Management's portfolio in Q1 2026, its #78 holding.
  • Advyzon Investment Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Advyzon Investment Management's Eli Lilly position peaked at $4.29M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Advyzon Investment Management's 13F filing for Q1 2026, filed 12 May 2026.